Phase I study of seliciclib (CYC202 or R-roscovitine) in combination with gemcitabine (gem)/cisplatin (cis) in patients with advanced non-small cell lung cancer (NSCLC)

W.S. Siegel-Lakhai, D.O. Rodenstein, J.H. Beijnen, A. Gianella-Borradori, J.H.M. Schellens, D.C. Talbot

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)150S-150S
JournalJournal of Clinical Oncology
Volume23
Issue number16
Publication statusPublished - 2005

Cite this